Lithium and glutamine synthetase: Protective effects following stress.


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
11 2019
Historique:
received: 26 02 2019
revised: 29 08 2019
accepted: 29 08 2019
pubmed: 10 9 2019
medline: 21 4 2020
entrez: 10 9 2019
Statut: ppublish

Résumé

Even though lithium is widely used as treatment for mood disorders, the exact mechanisms of lithium in the brain remain unknown. A potential mechanism affects the downstream target of the Wnt/β-catenin signaling pathway, specifically glutamine synthetase (GS). Here, we investigate the effect of lithium on GS-promoter activity in the brain. Over seven days, B6C3H-Glultm

Identifiants

pubmed: 31499341
pii: S0165-1781(19)30504-9
doi: 10.1016/j.psychres.2019.112544
pii:
doi:

Substances chimiques

Lithium Compounds 0
Psychotropic Drugs 0
beta Catenin 0
Sodium Chloride 451W47IQ8X
Glutamate-Ammonia Ligase EC 6.3.1.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112544

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Annakarina Mundorf (A)

Division of Experimental and Molecular Psychiatry, Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr-University Bochum, Bochum, 44780, Germany; Clinic for Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany.

Alexandra Knorr (A)

Division of Experimental and Molecular Psychiatry, Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr-University Bochum, Bochum, 44780, Germany.

Charlotte Mezö (C)

Clinic for Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany.

Christina Klein (C)

Division of Experimental and Molecular Psychiatry, Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr-University Bochum, Bochum, 44780, Germany.

Dominik Ke Beyer (DK)

Division of Experimental and Molecular Psychiatry, Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr-University Bochum, Bochum, 44780, Germany; Clinic for Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany.

Andreas J Fallgatter (AJ)

Clinic for Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany.

Michael Schwarz (M)

Institute of Pharmacology and Toxicology, University of Tuebingen, Tuebingen, Germany.

Nadja Freund (N)

Division of Experimental and Molecular Psychiatry, Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr-University Bochum, Bochum, 44780, Germany; Clinic for Psychiatry and Psychotherapy, University of Tuebingen, Tuebingen, Germany. Electronic address: nadja.freund@rub.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH